Literature DB >> 6939323

Depression: treatment compliance in general practice.

D A Johnson.   

Abstract

A survey of over two hundred patients attending fourteen family doctors in five different practices investigates the treatment in general practice of patients suffering from depressive illness. Medication was the principal treatment offered, but was often inadequate either because of prescription variables or because patients failed to comply with the treatment prescribed. The reasons for patient non-compliance fell into three main categories (a) side effects, (b) attitudes to drugs, (c) patient--doctor communication failure. It is suggested that a more extensive discussion of mental illness and its treatment is required as part of the total treatment of the individual, that the family doctor should take a more active role in the supervision of the treatment regimen, and that drugs with fewer side effects, particularly anticholinergic effects, are all required as essential measures to improve patient compliance with treatment.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6939323     DOI: 10.1111/j.1600-0447.1981.tb00751.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand Suppl        ISSN: 0065-1591


  20 in total

Review 1.  Recognition and management of depression in general practice: consensus statement.

Authors:  E S Paykel; R G Priest
Journal:  BMJ       Date:  1992-11-14

Review 2.  Managing depression in primary care.

Authors:  N Freemantle; F Song; T A Sheldon; P Watson; J M Mason; A F Long
Journal:  Qual Health Care       Date:  1993-03

Review 3.  Pharmacoeconomic evaluation of antidepressants : a critical appraisal of methods.

Authors:  Sheikh Usman Iqbal; Mark Prashker
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 4.  Putting trials on trial--the costs and consequences of small trials in depression: a systematic review of methodology.

Authors:  M Hotopf; G Lewis; C Normand
Journal:  J Epidemiol Community Health       Date:  1997-08       Impact factor: 3.710

Review 5.  Constraints on antidepressant prescribing and principles of cost-effective antidepressant use. Part 1: Depression and its treatment.

Authors:  J A Henry; C A Rivas
Journal:  Pharmacoeconomics       Date:  1997-05       Impact factor: 4.981

Review 6.  Selective serotonin reuptake inhibitors. Assessment for formulary inclusion.

Authors:  B H Guze
Journal:  Pharmacoeconomics       Date:  1996-05       Impact factor: 4.981

Review 7.  Constraints on antidepressant prescribing and principles of cost-effective antidepressant use. Part 2: Cost-effectiveness analyses.

Authors:  J A Henry; C A Rivas
Journal:  Pharmacoeconomics       Date:  1997-06       Impact factor: 4.981

Review 8.  Selective serotonin reuptake inhibitors in older patients. A tolerability perspective.

Authors:  U Skerritt; R Evans; S A Montgomery
Journal:  Drugs Aging       Date:  1997-03       Impact factor: 3.923

9.  Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care.

Authors:  L M Mynors-Wallis; D H Gath; A R Lloyd-Thomas; D Tomlinson
Journal:  BMJ       Date:  1995-02-18

10.  The use of antidepressant drugs in general practice. A questionnaire survey.

Authors:  K Matthews; J M Eagles; C A Matthews
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.